Bray F, Laversanne M, Weiderpass E, Soerjomataram I (2021) The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127(16):3029–3030. https://doi.org/10.1002/cncr.33587

Article  PubMed  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

Article  PubMed  Google Scholar 

Giavina-Bianchi P, Patil SU, Banerji A (2017) Immediate hypersensitivity reaction to chemotherapeutic agents. J Allergy Clin Immunol Pract. 5(3):593–599. https://doi.org/10.1016/j.jaip.2017.03.015

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

Jerschow E, Lin RY, Scaperotti MM, McGinn AP (2014) Fatal anaphylaxis in the United States, 1999–2010: Temporal patterns and demographic associations. J Allergy Clin Immunol 134(6):1318–1328.e7. https://doi.org/10.1016/j.jaci.2014.08.018

Article  PubMed  PubMed Central  Google Scholar 

Picard M, Pur L, Caiado J et al (2016) Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions. J Allergy Clin Immunol 137(4):1154–1164.e12. https://doi.org/10.1016/j.jaci.2015.10.039

Article  CAS  PubMed  Google Scholar 

Bonamichi-Santos R, Castells M (2018) Diagnoses and management of drug hypersensitivity and anaphylaxis in cancer and chronic inflammatory diseases: Reactions to taxanes and monoclonal antibodies. Clin Rev Allergy Immunol 54(3):375–385. https://doi.org/10.1007/s12016-016-8556-5

Article  CAS  PubMed  Google Scholar 

Kendirlinan R, Gümüşburun R, Çerçi P et al (2019) Rapid drug desensitization with chemotherapeutics (platins, taxanes, and others): a single-center retrospective study. Int Arch Allergy Immunol 179(2):114–122. https://doi.org/10.1159/000496745

Article  CAS  PubMed  Google Scholar 

de las Vecillas Sánchez L, Alenazy LA, Garcia-Neuer M, Castells MC (2017) Drug hypersensitivity and desensitizations: Mechanisms and new approaches. Int J Mol Sci 18(6):1316. https://doi.org/10.3390/ijms18061316

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jimenez-Rodriguez TW, Garcia-Neuer M, Alenazy LA, Castells M (2018) Anaphylaxis in the 21st century: Phenotypes, endotypes, and biomarkers. J Asthma Allergy 11:121–142. https://doi.org/10.2147/JAA.S159411

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sendo T, Sakai N, Itoh Y et al (2005) Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy. Cancer Chemother Pharmacol 56(1):91–96. https://doi.org/10.1007/s00280-004-0924-9

Article  CAS  PubMed  Google Scholar 

Castells M (2017) Drug hypersensitivity and anaphylaxis in cancer and chronic inflammatory diseases: The role of desensitizations. Front Immunol 8(NOV). https://doi.org/10.3389/fimmu.2017.01472

Caiado J, Brás R, Paulino M, Costa L, Castells M (2020) Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic: Outcomes and risk factors. Ann Allergy Asthma Immunol 125(3):325–333.e1. https://doi.org/10.1016/j.anai.2020.04.017

Article  CAS  PubMed  Google Scholar 

Castells MC (2015) Anaphylaxis to chemotherapy and monoclonal antibodies. Immunol Allergy Clin North Am 35(2):335–348. https://doi.org/10.1016/j.iac.2015.01.011

Article  PubMed  Google Scholar 

Feldweg AM, Lee CW, Matulonis UA, Castells M (2005) Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: A new standard protocol used in 77 successful treatments. Gynecol Oncol 96(3):824–829. https://doi.org/10.1016/j.ygyno.2004.11.043

Article  CAS  PubMed  Google Scholar 

Castells Guitart M (2014) Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century. J Investig Allergol Clin Immunol 24(2):72–79

Google Scholar 

Dizon DS, Schwartz J, Rojan A et al (2006) Cross-sensitivity between paclitaxel and docetaxel in a women’s cancers program. Gynecol Oncol 100:149–151. https://doi.org/10.1016/j.ygyno.2005.08.004

Article  CAS  PubMed  Google Scholar 

Banerji A, Lax T, Guyer A, Hurwitz S, Camargo CA, Long AA (2014) Management of hypersensitivity reactions to carboplatin and paclitaxel in an outpatient oncology infusion center: A 5-year review. J Allergy Clin Immunol Pract 2(4):428–433. https://doi.org/10.1016/j.jaip.2014.04.010

Article  PubMed  Google Scholar 

Madrigal-Burgaleta R, Bernal-Rubio L, Berges-Gimeno MP, Carpio-Escalona LV, Gehlhaar P, Alvarez-Cuesta E (2019) A large single-hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents. J Allergy Clin Immunol Pract 7(2):618–632. https://doi.org/10.1016/j.jaip.2018.07.031

Article  PubMed  Google Scholar 

Ratanajarusiri T, Sriuranpong V, Sitthideatphaiboon P et al (2017) Difference in the incidences of hypersensitivity reactions to original and generic taxanes. Chemotherapy 62(2):134–139. https://doi.org/10.1159/000450748

Article  CAS  PubMed  Google Scholar 

Castells M (2017) Diagnosis and management of anaphylaxis in precision medicine. J Allergy Clin Immunol 140(2):321–333. https://doi.org/10.1016/j.jaci.2017.06.012

Article  PubMed  Google Scholar 

Picard M (2017) Management of Hypersensitivity Reactions to Taxanes. Immunol Allergy Clin North Am 37(4):679–693. https://doi.org/10.1016/j.iac.2017.07.004

Article  PubMed  Google Scholar 

Campos L, Hamadi SA, Lynch DM, Marquis K, Castells MC (2019) Update on desensitization. Curr Treat Opt Allergy 6(4):519–537. https://doi.org/10.1007/s40521-019-00231-0

Article  Google Scholar 

Jensen-Jarolim E, Bax HJ, Bianchini R et al (2017) AllergoOncology – the impact of allergy in oncology: EAACI position paper. Allergy Eur J Allergy Clin Immunol 72(6):866–887. https://doi.org/10.1111/all.13119

Article  CAS  Google Scholar 

Pagani M (2018) Options in hypersensitivity reactions to chemotherapeutics. Curr Treat Opt Allergy 5(1):118–132. https://doi.org/10.1007/s40521-018-0160-x

Article  Google Scholar 

Brown SGA (2004) Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 114(2):371–376. https://doi.org/10.1016/j.jaci.2004.04.029

Article  PubMed  Google Scholar 

Picard M, Castells MC (2015) Re-visiting hypersensitivity reactions to taxanes: A comprehensive review. Clin Rev Allergy Immunol 49(2):177–191. https://doi.org/10.1007/s12016-014-8416-0

Article  CAS  PubMed  Google Scholar 

García AP, Pineda De La Losa F (2010) Immunoglobulin E-mediated severe anaphylaxis to paclitaxel. J Investig Allergol Clin Immunol 20(2):170–176

Google Scholar 

Caiado J, Picard M (2014) Diagnostic tools for hypersensitivity to platinum drugs and taxanes: Skin testing, specific IgE, and mast cell/basophil mediators. Curr Allergy Asthma Rep 14(8). https://doi.org/10.1007/s11882-014-0451-7

Villarreal-González RV, González Díaz SN, de la Cruz Cruz RA, Vidal Gutiérrez O, de Lira Quezada CE (2022) Hypersensitivity reactions to paclitaxel: The Mexican experience of rapid desensitization. J Oncol Pharm Pract 28(3):598–604

Article  Google Scholar 

Otani IM, Lax T, Long AA, Slawski BR, Camargo CA, Banerji A (2018) Utility of risk stratification for paclitaxel hypersensitivity reactions. J Allergy Clin Immunol Pract 6(4):1266–1273.e2. https://doi.org/10.1016/j.jaip.2017.08.025

Article  PubMed  Google Scholar 

Price KS, Castells MC (2002) Taxol reactions. Allergy Asthma Proc 23(3):205–208

PubMed  Google Scholar 

Moher D, Shamseer L, Clarke M et al (2016) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Revista Espanola de Nutricion Humana y Dietetica 20(2):148–160. https://doi.org/10.1186/2046-4053-4-1

Article  Google Scholar 

Lee CW, Matulonis UA, Castells MC (2005) Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: Standard protocol effective in 57 patients for 255 courses. Gynecol Oncol 99(2):393–399. https://doi.org/10.1016/j.ygyno.2005.06.028

Article  PubMed  Google Scholar 

Gastaminza G, de La Borbolla JM, Goikoetxea MJ et al (2011) A new rapid desensitization protocol for chemotherapy agents. J Investig Allergol Clin Immunol 21(2):108–112

CAS  PubMed  Google Scholar 

Kuo J, Hawkins C, Yip D (2014) Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions. Intern Med J 44(5):441–442. https://doi.org/10.1111/imj.12423

Article  Google Scholar 

Pagani M, Bavbek S, Dursun AB et al (2019) Role of skin tests in the diagnosis of immediate hypersensitivity reactions to taxanes: Results of a multicenter study. J Allergy Clin Immunol Pract 7(3):990–997. https://doi.org/10.1016/j.jaip.2018.09.018

Article  PubMed  Google Scholar 

Castells MC, Tennant NM, Sloane DE et al (2008) Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 122(3):574–580. https://doi.org/10.1016/j.jaci.2008.02.044

Article  CAS  PubMed  Google Scholar 

Sánchez-Muñoz A, Jiménez B, García-Tapiador A et al (2011) Cross-sensitivity between taxanes in patients with breast cancer. Clin Transl Oncol 13(12):904–906. https://doi.org/10.1007/s12094-011-0753-3

Article